2024 annual financial data
ACADIA Pharmaceuticals 2024 Net income growth
Direct answer
Net income growth was 469.5%.
Operating income was 230,794,000 USD and net income was 226,451,000 USD.
Operating cash flow was 157,719,000 USD.
Get free ACADIA Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 957,797,000 USD
- Operating income
- 230,794,000 USD
- Net income
- 226,451,000 USD
- Operating cash flow
- 157,719,000 USD